The global Stem Cell Manufacturing market gathered revenue around USD 10.2 Billion in 2020 and market is set to grow USD 20.1 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 11% during the prediction period 2021 to 2027. Growing investments in stem cell-based research, rising awareness about the therapeutic potency of stem cell products, and supportive regulatory framework across developing countries are the key factors supporting the growth of the market. Stem cells play an important role in effective disease management as well as specialized research initiatives, such as personalized medicine and genomic testing. Owing to the growing awareness about the therapeutic potency of stem cells and the limited availability of therapeutic treatments for orphan diseases, various public and private stakeholders across the globe are increasingly investing in the development of stem cell-based technologies.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Stem Cell Manufacturing market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Stem Cell Manufacturing market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Stem Cell Manufacturing market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America accounted for the largest share of the stem cell manufacturing market in 2020.
In 2020, North America accounted for the largest share of the stem cell manufacturing market, followed by Europe. The large share of the North American regional segment can be attributed to the extensive ongoing stem cell research activities, and the availability of public-private funding and grants to support the clinical evaluation of stem cells for various applications.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Stem Cell Manufacturing Market are:
The major market players include Thermo Fisher Scientific (US), Merck Millipore (Germany), Lonza Group AG (Switzerland), Danaher Corporation (US), Sartorius AG (Germany), Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), Stemcell Technologies (Canada), Fujifilm Holdings Corporation (Japan), Miltenyi Biotec (Germany), Terumo BCT Inc. (US), Corning Inc. (US), Bio-Techne Corporation (US), Takara Bio Group (Japan), Eppendorf AG (Germany), Getinge (Sweden), Himedia Laboratories (India), Anterogen (South Korea), Cellgenix GMBH (Germany) and Promocell (Germany).
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Product
By Application
By End User
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Stem Cell Manufacturing Market, By Product
7.1. Stem Cell Manufacturing Market, By Product, 2021-2027
7.1.1. Consumables
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Instruments
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Instruments
7.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Stem Cell Manufacturing Market, By Application
8.1. Stem Cell Manufacturing Market, by Application, 2021-2027
8.1.1. Research Applications
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Clinical Application
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Cell & Tissue Banking Applications
8.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Stem Cell Manufacturing Market, By End User
9.1. Stem Cell Manufacturing Market, by End User, 2021-2027
9.1.1. Research Applications
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Academic institutes, Research laboratories & contract research organizations
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Hospitals & surgical centres
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Cell & tissue banks
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Other End Users
9.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Stem Cell Manufacturing Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Product (2016-2027)
10.1.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.3. Market Revenue and Forecast, by End User (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.1.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.1.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.3. Market Revenue and Forecast, by End User (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.6.3. Market Revenue and Forecast, by End User (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.7.3. Market Revenue and Forecast, by End User (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.3. Market Revenue and Forecast, by End User (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.6.3. Market Revenue and Forecast, by End User (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.7.3. Market Revenue and Forecast, by End User (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.6.3. Market Revenue and Forecast, by End User (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.7.3. Market Revenue and Forecast, by End User (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.5.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.5.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.5.3. Market Revenue and Forecast, by End User (2016-2027)
Chapter 11. Company Profiles
11.1. Thermo Fisher Scientific
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Merck Millipore
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Lonza Group AG
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Danaher Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Sartorius AG
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Bio-Rad Laboratories
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Becton
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Dickinson and Company
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Stemcell Technologies
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Fujifilm Holdings Corporation
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms